Evidence Hub

Phase 1/1b study of direct intratumoral injection of pleural mesothelioma of immunostimulant prior to surgical resection

Andrea S. Wolf, Shubham Gulati, K. Dolasia, Bailey G. Fitzgerald, Jorge E. Gomez, D. Yankelevitz, Andres Salazar, A. Tsankov et al.

Journal of Thoracic and Cardiovascular Surgery, 2026

7 participants

Abstract

OBJECTIVE

To evaluate the role of neoadjuvant injection of the viral mimic poly-ICLC (polyinosinic-polycytidylic acid-poly-l-lysine carboxymethylcellulose) in patients with pleural mesothelioma undergoing curative-intent surgical resection.

METHODS

Patients with documented pleural mesothelioma who were deemed resectable underwent intratumoral injection of poly-ICLC 2-4 weeks prior to planned curative-intent surgery. Safety and toxicity were the primary endpoints. Secondary endpoints were postoperative complications, mortality, and overall survival (OS), with patients censored at the date of last follow-up if not known to be deceased.

RESULTS

Between 2020 and 2024, 19 patients underwent treatment followed by pleurectomy/decortication a median of 19 days (range, 14-192 days) later. Poly-ICLC was well tolerated, with drug-related grade I toxicities occurring in 7 patients (37%). All patients were resectable and had the diaphragm and pericardium preserved. The median length of stay was 7 days (range, 3-19 days), postoperative complications were minor, except 1 cardiac arrest due to complete heart block, and there were no deaths within 90 days of surgery. The median OS was 19.6 months from injection (95% confidence interval [CI], 14.7 months to not reached [NR]) and 19.1 months from surgery (95% CI, 13.4 months to NR). One patient in whom surgery was delayed and who underwent systemic chemotherapy following injection was found to have a complete response to poly-ICLC and systemic…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free